LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

Kodu・Aktsiate loetelu・CVS Health Corp.

CVS Health Corp.

Suletud

SektorTervishoid

95.98 1.22

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

95.29

Max

96.12

Põhinäitajad
By Trading Economics
Sissetulek	14M 3B
Müük	-5.3B 100B
P/E Sektori keskmine	39.746 49.888
Aktsiakasum	2.57
Dividenditootlus	2.92
Kasumimarginaal	2.944
Töötajad	219,000
EBITDA	2.5B 5.8B

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+7.73% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	2.92% 2.38%
Järgmine tulemuste avaldamine	30. juuli 2026
Järgmine dividendimakse kuupäev	31. juuli 2026
Järgmine aktsia dividendi kuupäev (ex-date)	21. juuli 2026

Turustatistika
By TradingEconomics
Turukapital	11B 116B
Eelmine avamishind	94.76
Eelmine sulgemishind	95.98

Uudiste sentiment

By Acuity

19%

81%

25 / 344 Pingereas Healthcare

CVS Health Corp. Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

13. mai 2026, 20:00 UTC

Omandamised, ülevõtmised, äriostud

Omnicare Receives Court Approval for Sale of Business to GenieRx

6. mai 2026, 11:02 UTC

Tulu

CVS Health Stock Jumps After Earnings. What's Encouraging Wall Street. -- Barrons.com

6. mai 2026, 10:47 UTC

Tulu

CVS Health Stock Jumps After Earnings. What's Encouraging Wall Street. -- Barrons.com

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Net $2.94B >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Front Store Same-Store Sales Up 1.2% >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health Sees FY Adj EPS $7.30-Adj EPS $7.50 >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Health Services Segment Revenue Up 11.0% >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health Sees FY Net $8.03B-Net $8.29B >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health Sees FY EPS $6.24-EPS $6.44 >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q EPS $2.30 >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Healthcare Benefits Segment Revenue Up 3.3% >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Adj EPS $2.57 >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health Health Care Benefits Segment's 1Q Medical Benefit Ratio 84.6% >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health Updates 2026 Cash Flow From Operations Guidance to at Least $9.5B From at Least $9B >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health Increasing Full-Year 2026 EPS, Adj EPS and Cash Flow From Operations Guidance to Reflect Increases in Health Care Benefits and Pharmacy & Consumer Wellness Segments >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Prescriptions Filled Rose 3.6% on 30-Day Equivalent Basis >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health: 1Q Adjusted EPS Rose Primarily Due to Improved Adjusted Operating Income in Health Care Benefits Segment >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health: Maintaining a Cautious View for Remainder of the Year in Light of Continued Elevated Cost Trends and Potential for Macro Headwinds >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Healthcare Benefits Segment Revenue Up 3.3% >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health: 1Q Health Services Segment Rev Rose Primarily Driven by Pharmacy Drug Mix and Brand Inflation, Partially Offset by Continued Pharmacy Client Price Improvements >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health: 1Q Health Care Benefits Segment Rev Rose Primarily Driven by Increase in Govt Business, Partially Offset by Decline as Result of CO's Exit of Individual Exchange Business in 2026 >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Pharmacy & Consumer Wellness Segment Revenue Flat >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health: 1Q Adj. Operating Income $5.15B >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Same-Store Prescription Volume Rose 6.8% >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Pharmacy & Consumer Wellness Segment Revenue $31.99B >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Front Store Same-Store Sales Up 1.2% >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health Raises 2026 View To EPS $6.24-EPS $6.44 Vs Prior View $5.94-$6.14 >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q Pharmacy Same-Store Sales Up 3.1% >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health Raises 2026 View To Adj EPS $7.30-Adj EPS $7.50 Vs Prior View $7-$7.20 >CVS

6. mai 2026, 10:30 UTC

Tulu

CVS Health 1Q EPS $2.30 >CVS

Võrdlus sarnastega

Hinnamuutus

CVS Health Corp. Prognoos

Hinnasiht

By TipRanks

7.73% tõus

12 kuu keskmine prognoos

Keskmine 103.35 USD 7.73%

Kõrge 111 USD

Madal 92 USD

Põhineb 18 Wall Streeti analüütiku instrumendi CVS Health Corp. 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

18 ratings

Osta

Hoia

Müü

Põhineb 18 analüütiku instrumendi CVS Health Corp. aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

25 / 344 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest CVS Health Corp.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.